Clinical Trials Sponsored by Oxo Chemie GmbH

Total 27 results

Oxo Chemie GmbH

Completed

A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV Infection

HIV Infections

United States
Oxo Chemie GmbH

Completed

A Study of WF 10 IV Solution in Patients With Advanced HIV Disease

HIV Infections

United States
Dr. F. Köhler Chemie GmbH

Active, not recruiting

Study of Organ Perfusion in Heart Transplantation in Children

Heart Transplantation

Germany
Dr. F. Köhler Chemie GmbH

Completed

Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation

Heart Failure

Austria, Germany
Dr. F. Köhler Chemie GmbH

Completed

Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery

Coronary Artery Disease (CAD)

Germany
Dr. F. Köhler Chemie GmbH

Recruiting

Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)

Kidney Failure | Liver Failure, Chronic | Kidney-Pancreas Failure

Austria
Dr. F. Köhler Chemie GmbH

Completed

Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol (Custodiol-AV)

Aortic Valve Disease | Coronary Artery Disease (CAD)

Germany
OXO Chemie

Completed

A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease

HIV Infections

Canada, United States
Themis Bioscience GmbH

Completed

Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability (V186-001)

Zika Virus

Austria
Themis Bioscience GmbH

Completed

Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine (MV-CHIK-202)

Chikungunya Virus Infection

Austria, Germany
Themis Bioscience GmbH

Completed

Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)

Chikungunya Virus Infection

United Kingdom
Themis Bioscience GmbH

Completed

Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001) (MV-ZIKA-RSP)

Zika Virus Infection

Austria
Srinakharinwirot University
Oxo Chemie(Thailand) Co.,Ltd.; Altermed Co.,Ltd.

Completed

Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

Diabetic Foot Ulcer (DFU) | Uncontrolled Diabetes With Foot Ulcer

Thailand
Vanderbilt University Medical Center
DR. FRANZ KOHLER CHEMIE GMBH

Completed

Cholinesterase Activity and DeliriUm During Critical Illness Study (CADUCeuS)

Delirium | Cognitive Impairment

United States
Themis Bioscience GmbH
Assign Data Management and Biostatistics GmbH; Optimapharm

Withdrawn

A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract

Gastrointestinal Cancer

Germany
Ardeypharm GmbH
ICON plc; Clinscience Sp. z o.o.

Completed

E. Coli Nissle 1917 - Suspension for Infection Prophylaxis (RONi)

Infections

Germany, Poland
Themis Bioscience GmbH
Walter Reed Army Institute of Research (WRAIR)

Completed

Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area

Chikungunya

Puerto Rico
Institut Pasteur
Coalition for Epidemic Preparedness Innovations; Themis Bioscience GmbH

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine (COVID-19-101)

COVID-19

Belgium, France
Themis Bioscience GmbH
Walter Reed Army Institute of Research (WRAIR)

Completed

Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)

Chikungunya Virus Infection

Puerto Rico
Technical University of Munich
Bayer; Organon; Sanofi-Synthelabo; AOK Bayern; Ratiopharm GmbH; Berlin-Chemie Menarini and other collaborators

Terminated

Prevention of Stroke and Dementia in Primary Care (INVADE)

Stroke | Dementia | Disability

Germany
Mylan Inc.
Mylan Österreich GmbH; Mylan Germany GmbH; Mylan Healthcare Sp. z o.o.

Completed

Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical

Hypercholesterolemia

Germany, Austria
Themis Bioscience GmbH
Assign Data Management and Biostatistics GmbH; Coalition for Epidemic Preparedness... and other collaborators

Completed

A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)

Lassa Virus Infection

Belgium
Medical University Innsbruck
Charite University, Berlin, Germany; University Hospital, Ghent; University of... and other collaborators

Completed

Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation

Diabetes Mellitus | Pancreas Transplantation

Austria, Belgium, Germany
PD Dr. Bertram Scheller
Goethe University; Dr. Franz Köhler Chemie GmbH (study medication and labeling)

Unknown

Evaluation if Physostigmine Reduces Symptoms in Patients Who Has Developed a Delirium in Intensive Care After a Surgery

Suspected Delirium After Elective or Emergency Heart Surgery | CAM-ICU Diagnosed Delirium

Germany
Hasselt University
Jessa Hospital; University of Warwick; University of Zagreb; Claude Bernard University and other collaborators

Completed

Fast Assay for Pathogen Identification and Characterization (FAPIC)

Sepsis | Septic Shock | Bacteremia

Belgium
Hasselt University
Jessa Hospital; University of Warwick; Claude Bernard University; AIT Austrian... and other collaborators

Completed

Fast Assay for Pathogen Identification - Quasi-Experimental Intervention Study (FAPIC-QE)

Sepsis | Septic Shock | Bacteremia

Belgium
Medical University Innsbruck
Barmherzige Brüder Vienna; Tiroler Landeskrankenanstalten GmbH (TILAK); Tiroler... and other collaborators

Completed

Post-Stroke Disease Management - Stroke Card (Stroke Card)

Stroke | Ischemic Attack, Transient | Cost-Benefit Analysis | Secondary Prevention | Disease Management

Austria

Clinical Trials Sponsored by Oxo Chemie GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations